FDA OK’s first novel treatment for Parkinson’s in ten years
The US Food and Drug Administration has approved the first novel treatment option in more than a decade for patients with Parkinson’s disease experiencing ‘off’ episodes while being treated with levodopa/carbidopa.
Read More
